ALS drug QRL-101 tested in small safety study
Knowledge-focused
Completed
This early-phase study tested a single dose of the experimental drug QRL-101 in 12 people with ALS. The main goal was to understand how the drug moves through the body and how it affects nerve signals, while also checking for safety. Participants received either QRL-101 or a plac…
Phase: PHASE1 • Sponsor: QurAlis Corporation • Aim: Knowledge-focused
Last updated May 17, 2026 13:26 UTC